Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HLA class I B44 is associated with sustained response to interferon + ribavirin therapy in patients with chronic hepatitis C.

The American journal of gastroenterology - 1 Jul 2003

Romero-Gómez Manuel, González-Escribano María Francisca, Torres Belén, Barroso Natalia, Montes-Cano Marco Antonio, Sánchez-Muñoz Diego, Núñez-Roldan Antonio, Aguilar-Reina José

Abstract excerpt

OBJECTIVE: The aim of this study was to assess the influence of host genetic factors on response to combination therapy for chronic hepatitis C infection. METHODS: Patients with biopsy-proved chronic hepatitis C infection were treated with interferon alone (n = 143) or combined therapy of interfe...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Therapy, Combination
Share to Hepatitis C, Chronic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Histocompatibility Antigens Class II

Share to HLA-B Antigens

Share to HLA-B44 Antigen

Share to Interferons

Share to Multivariate Analysis

Share to Ribavirin

Source

Identifiers

PMID: 12873589
DOI: 10.1111/j.1572-0241.2003.07537.x

Genes

TNF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-12873589-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HLA class I B44 is associated with sustained response to interferon + ribavirin therapy in patients with chronic hepatitis C.PMID 12873589Read ↗

Importance of host genetic factors HLA and IL28B as predictors of response to pegylated interferon and ribavirin.Semantic proximity Read ↗

Influence of HLA alleles in response to treatment with pegylated interferon-alpha and ribavirin in patients with chronic hepatitis C.Semantic proximity Read ↗

Response to interferon therapy: influence of human leucocyte antigen alleles in patients with chronic hepatitis C.Semantic proximity Read ↗

[HLA class II alleles and response to hepatitis C treatment with interferon alpha2b].Semantic proximity Read ↗

Prognostic effect of human leukocyte antigen class I and II alleles on chronic hepatitis C patients treated by pegylated interferon-alfa plus ribavirin in Taiwan.Semantic proximity Read ↗

Human leukocyte antigen class I alleles can predict response to pegylated interferon/ribavirin therapy in chronic hepatitis C Egyptian patients.Semantic proximity Read ↗

Genetic polymorphisms in interferon pathway and response to interferon treatment in hepatitis B patients: A pilot studySemantic proximity Read ↗

Homozygosity for HLA group 2 alleles predicts treatment failure with interferon-α and ribavirin in chronic hepatitis C virus genotype 1 infection.Semantic proximity Read ↗

Human leukocyte antigen class II alleles (DQB1 and DRB1) as predictors for response to interferon therapy in HCV genotype 4.Semantic proximity Read ↗

Association between polymorphisms of the cytokine and cytokine receptor genes and immune response to hepatitis B vaccination in a Chinese Han population.Semantic proximity Read ↗

Relationship between HLA-DR gene polymorphisms and outcomes of hepatitis B viral infections: a meta-analysis.Semantic proximity Read ↗

The interaction of genetic determinants in the outcome of HCV infection: evidence for discrete immunological pathways.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.